Selected research
Industry Growth & Trends
Global Rofecoxib Industry Growth and Trends Forecast to 2032
Market perspective
The global Rofecoxib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Rofecoxib include Wuhan Xinxin Jiali Biotechnology Co. LTD, Merck, Pfizer, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Chengdu Meinkai Chemical Co. LTD and Tremeau, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Rofecoxib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Rofecoxib market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rofecoxib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rofecoxib.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Rofecoxib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Rofecoxib Market by Company
Wuhan Xinxin Jiali Biotechnology Co. LTD
Merck
Pfizer
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Chengdu Meinkai Chemical Co. LTD
Tremeau
Rofecoxib Segment by Type
Oral Suspension.
Tablet-Form
Rofecoxib Segment by Application
Juvenile Rheumatoid Arthritis
Dysmenorrhea
Migraine
Rheumatoid Arthritis
Acute Pain Conditions
Osteoarthritis
Rofecoxib Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rofecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rofecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rofecoxib.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rofecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Suspension.
- Tablet-Form
Applications
- Juvenile Rheumatoid Arthritis
- Dysmenorrhea
- Migraine
- Rheumatoid Arthritis
- Acute Pain Conditions
- Osteoarthritis
Companies covered
- Wuhan Xinxin Jiali Biotechnology Co. LTD
- Merck
- Pfizer
- Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
- Chengdu Meinkai Chemical Co. LTD
- Tremeau
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Rofecoxib Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Rofecoxib Sales Estimates and Forecasts (2021-2032)
- 1.3 Rofecoxib Market by Type
- 1.3.1 Oral Suspension.
- 1.3.2 Tablet-Form
- 1.4 Global Rofecoxib Market Size by Type
- 1.4.1 Global Rofecoxib Market Size Overview by Type (2021-2032)
- 1.4.2 Global Rofecoxib Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Rofecoxib Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Rofecoxib Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Rofecoxib Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Rofecoxib Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Rofecoxib Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Rofecoxib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Rofecoxib Industry Trends
- 2.2 Rofecoxib Industry Drivers
- 2.3 Rofecoxib Industry Opportunities and Challenges
- 2.4 Rofecoxib Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Rofecoxib Revenue (2021-2026)
- 3.2 Global Top Players by Rofecoxib Sales (2021-2026)
- 3.3 Global Top Players by Rofecoxib Price (2021-2026)
- 3.4 Global Rofecoxib Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Rofecoxib Major Company Production Sites & Headquarters
- 3.6 Global Rofecoxib Company, Product Type & Application
- 3.7 Global Rofecoxib Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Rofecoxib Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Rofecoxib Players Market Share by Revenue in 2025
- 3.8.3 2025 Rofecoxib Tier 1, Tier 2, and Tier 3
4 Rofecoxib Regional Status and Outlook
- 4.1 Global Rofecoxib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Rofecoxib Historic Market Size by Region
- 4.2.1 Global Rofecoxib Sales in Volume by Region (2021-2026)
- 4.2.2 Global Rofecoxib Sales in Value by Region (2021-2026)
- 4.2.3 Global Rofecoxib Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Rofecoxib Forecasted Market Size by Region
- 4.3.1 Global Rofecoxib Sales in Volume by Region (2027-2032)
- 4.3.2 Global Rofecoxib Sales in Value by Region (2027-2032)
- 4.3.3 Global Rofecoxib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rofecoxib by Application
- 5.1 Rofecoxib Market by Application
- 5.1.1 Juvenile Rheumatoid Arthritis
- 5.1.2 Dysmenorrhea
- 5.1.3 Migraine
- 5.1.4 Rheumatoid Arthritis
- 5.1.5 Acute Pain Conditions
- 5.1.6 Osteoarthritis
- 5.2 Global Rofecoxib Market Size by Application
- 5.2.1 Global Rofecoxib Market Size Overview by Application (2021-2032)
- 5.2.2 Global Rofecoxib Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Rofecoxib Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Rofecoxib Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Rofecoxib Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Rofecoxib Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Rofecoxib Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Rofecoxib Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Wuhan Xinxin Jiali Biotechnology Co. LTD
- 6.1.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
- 6.1.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
- 6.1.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio
- 6.1.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Rofecoxib Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Rofecoxib Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Rofecoxib Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Rofecoxib Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
- 6.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
- 6.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
- 6.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio
- 6.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
- 6.5 Chengdu Meinkai Chemical Co. LTD
- 6.5.1 Chengdu Meinkai Chemical Co. LTD Company Information
- 6.5.2 Chengdu Meinkai Chemical Co. LTD Business Overview
- 6.5.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio
- 6.5.5 Chengdu Meinkai Chemical Co. LTD Recent Developments
- 6.6 Tremeau
- 6.6.1 Tremeau Company Information
- 6.6.2 Tremeau Business Overview
- 6.6.3 Tremeau Rofecoxib Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Tremeau Rofecoxib Product Portfolio
- 6.6.5 Tremeau Recent Developments
7 North America by Country
- 7.1 North America Rofecoxib Sales by Country
- 7.1.1 North America Rofecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Rofecoxib Sales by Country (2021-2026)
- 7.1.3 North America Rofecoxib Sales Forecast by Country (2027-2032)
- 7.2 North America Rofecoxib Market Size by Country
- 7.2.1 North America Rofecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Rofecoxib Market Size by Country (2021-2026)
- 7.2.3 North America Rofecoxib Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Rofecoxib Sales by Country
- 8.1.1 Europe Rofecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Rofecoxib Sales by Country (2021-2026)
- 8.1.3 Europe Rofecoxib Sales Forecast by Country (2027-2032)
- 8.2 Europe Rofecoxib Market Size by Country
- 8.2.1 Europe Rofecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Rofecoxib Market Size by Country (2021-2026)
- 8.2.3 Europe Rofecoxib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Rofecoxib Sales by Country
- 9.1.1 Asia-Pacific Rofecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Rofecoxib Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Rofecoxib Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Rofecoxib Market Size by Country
- 9.2.1 Asia-Pacific Rofecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Rofecoxib Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Rofecoxib Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Rofecoxib Sales by Country
- 10.1.1 South America Rofecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Rofecoxib Sales by Country (2021-2026)
- 10.1.3 South America Rofecoxib Sales Forecast by Country (2027-2032)
- 10.2 South America Rofecoxib Market Size by Country
- 10.2.1 South America Rofecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Rofecoxib Market Size by Country (2021-2026)
- 10.2.3 South America Rofecoxib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Rofecoxib Sales by Country
- 11.1.1 Middle East and Africa Rofecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Rofecoxib Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Rofecoxib Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Rofecoxib Market Size by Country
- 11.2.1 Middle East and Africa Rofecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Rofecoxib Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Rofecoxib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Rofecoxib Value Chain Analysis
- 12.1.1 Rofecoxib Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Rofecoxib Production Mode & Process
- 12.2 Rofecoxib Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Rofecoxib Distributors
- 12.2.3 Rofecoxib Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst